SAN FRANCISCO, Nov. 27, 2025 (GLOBE NEWSWIRE) -- Medical device manufacturer Inspire Medical Systems, Inc. (NYSE: INSP) is the subject of a securities class action lawsuit following a sharp decline in its stock price, with shareholders alleging the company misled investors about the launch of its latest product, the Inspire V device for obstructive sleep apnea. Hagens Berman is investigating th...
SAN DIEGO , Nov. 26, 2025 /PRNewswire/ -- Company: Inspire Medical Systems, Inc. (NYSE: INSP) is a medical technology company. What is the class period?
INSP Investors with Losses Encouraged to Contact Hagens Berman SAN FRANCISCO , Nov. 25, 2025 /PRNewswire/ -- Medical device manufacturer Inspire Medical Systems, Inc. (NYSE: INSP) is the subject of a securities class action lawsuit following a sharp decline in its stock price, with shareholders alleging the company misled investors about the launch of its latest product, the Inspire V device fo...
LOS ANGELES , Nov. 25, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Inspire Medical Systems, Inc. ("Inspire" or the "Company") (NYSE: INSP) have opportunity to lead the securities fraud class action lawsuit.
Inspire Medical Systems' stock recently saw a significant surge, reacting to news that appears to be important. But does the increase from yesterday indicate that this is a good time to buy, or are we merely trying to catch a falling knife?
SAN FRANCISCO, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Medical device manufacturer Inspire Medical Systems, Inc. (NYSE: INSP) is the subject of a securities class action lawsuit following a sharp decline in its stock price, with shareholders alleging the company misled investors about the launch of its latest product, the Inspire V device for obstructive sleep apnea.
BENSALEM, Pa. , Nov. 21, 2025 /PRNewswire/ -- The Law Offices of Howard G.
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.